Overview Valacyclovir 1000 mg Tablet Under Fed Conditions Status: Completed Trial end date: 2004-09-01 Target enrollment: Participant gender: Summary The objective of this study was to compare the rate and extent of absorption of Teva Pharmaceuticals USA valacyclovir and GlaxoSmithKline, USA (Valtrex) valacyclovir, administered as 1 x 1000 mg tablet under fed conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: AcyclovirValacyclovir